Unity Biotechnology, a preclinical biotech developing therapies for aging-related diseases, filed on Thursday with the SEC to raise up to $85 million in an initial public offering. The Brisbane, CA-based company was founded in 2009 and booked $1 million in sales for the 12 months ended December 31, …
05
Apr